Smith & Nephew plc (NYSE:SNN - Get Free Report) saw a large increase in short interest in the month of May. As of May 15th, there was short interest totalling 1,880,000 shares, an increase of 22.9% from the April 30th total of 1,530,000 shares. Based on an average daily volume of 873,900 shares, the short-interest ratio is presently 2.2 days. Currently, 0.4% of the shares of the stock are sold short.
Smith & Nephew Trading Up 3.5%
SNN stock traded up $1.03 during trading on Thursday, hitting $30.30. The company had a trading volume of 897,246 shares, compared to its average volume of 792,059. The firm has a 50-day moving average price of $27.54 and a 200-day moving average price of $26.61. Smith & Nephew has a 12 month low of $23.69 and a 12 month high of $31.72. The company has a quick ratio of 1.11, a current ratio of 2.51 and a debt-to-equity ratio of 0.63. The stock has a market cap of $13.27 billion, a price-to-earnings ratio of 14.03, a PEG ratio of 1.26 and a beta of 0.68.
Analysts Set New Price Targets
SNN has been the subject of several analyst reports. Canaccord Genuity Group raised their target price on Smith & Nephew from $27.00 to $28.00 and gave the stock a "hold" rating in a research report on Thursday, May 1st. HSBC downgraded shares of Smith & Nephew from a "buy" rating to a "hold" rating in a research note on Friday, April 25th. Hsbc Global Res downgraded shares of Smith & Nephew from a "strong-buy" rating to a "hold" rating in a report on Friday, April 25th. Wall Street Zen raised shares of Smith & Nephew from a "buy" rating to a "strong-buy" rating in a research note on Wednesday, February 26th. Finally, UBS Group lowered shares of Smith & Nephew from a "buy" rating to a "neutral" rating in a report on Wednesday, March 12th. Six investment analysts have rated the stock with a hold rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and a consensus target price of $28.00.
Get Our Latest Stock Report on Smith & Nephew
Institutional Trading of Smith & Nephew
Several institutional investors and hedge funds have recently added to or reduced their stakes in SNN. Blue Trust Inc. raised its holdings in Smith & Nephew by 26.0% during the 4th quarter. Blue Trust Inc. now owns 5,871 shares of the medical equipment provider's stock worth $144,000 after purchasing an additional 1,213 shares during the last quarter. R Squared Ltd bought a new position in shares of Smith & Nephew in the 4th quarter worth $41,000. Bleakley Financial Group LLC grew its stake in shares of Smith & Nephew by 3.5% during the fourth quarter. Bleakley Financial Group LLC now owns 17,704 shares of the medical equipment provider's stock worth $435,000 after purchasing an additional 596 shares during the period. Van ECK Associates Corp grew its stake in shares of Smith & Nephew by 111.2% during the fourth quarter. Van ECK Associates Corp now owns 9,240 shares of the medical equipment provider's stock worth $227,000 after purchasing an additional 4,865 shares during the period. Finally, ABC Arbitrage SA acquired a new position in Smith & Nephew in the fourth quarter valued at about $4,847,000. 25.64% of the stock is owned by institutional investors.
About Smith & Nephew
(
Get Free Report)
Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT.
Featured Articles
Before you consider Smith & Nephew, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Smith & Nephew wasn't on the list.
While Smith & Nephew currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.